Resources

HairSkin®Human skin model with hair folliclesHairSkin®: the first ex vivo human skin model with mature pilosebaceous units HairSkin® is a cutting-edge ex vivo human skin model, developed with tissue containing fully mature pilosebaceous units. HairSkin® is designed to meet the requirements of both pharmaceutical and cosmetic industries and to empower innovation in dermatology, cosmetics, and personal care. Thanks to aRead more

From human skin to human data: Advancing immunogenicity testing with human modelsIn a public workshop organized by the FDA-CRCG group, Dr. Nicolas Gaudenzio, CSO of Genoskin, introduced an innovative platform for assessing immune responses in response to injected substances using human skin explants. His talk, titled "A new in vitro framework for assessing immunogenicity using comprehensive profiling of injectable humanRead more

Top-level science through the eyes of an expert. Join us for the 9th webinar in Genoskin’s scientific series, where we continue to explore groundbreaking advancements in immunology and human skin biology. This session will feature an in-depth presentation by Dr. Etienne Meunier, a leading expert in inflammasome biology and innate immunity, group leader at IPBS, Toulouse, France. This episode of the NakedRead more

Top things found in human skin (vs in reconstructed human skin models) Covering nearly two square meters, skin is our body’s largest organ and a common pathway for administering drugs—whether through topical applications, subcutaneous injections, intradermal routes, or medical devices. With its complex network of immune cells, the skin plays an essential role in testing the efficacy and safety ofRead more

This application note highlights new comparative data on T cell dynamics in HypoSkin^® and InflammaSkin^®, generated using flow cytometric analysis.

Research HighlightExplore our latest publication in Allergy: the story behind the idea and key findings.The landscape of vaccine research is undergoing an important transformation, thanks to the breakthroughs in mRNA vaccine technology. This innovation has catalyzed the development of vaccines that are not only highly effective but also rapidly deployable at a large scale. With the increasing number of researchRead more